Last updated: September 27, 2025
Introduction
South Korean patent KR20120115972 exemplifies the strategic approach of pharmaceutical innovators aiming to patent novel drug compositions, methods of treatment, and specific formulations. This patent plays a crucial role within the broader South Korean patent landscape due to its scope, claims, and the landscape it influences. Understanding these elements provides insight into IP protection strategies, competitive positioning, and the dynamic environment of pharmaceutical innovation within Korea.
Scope of Patent KR20120115972
KR20120115972 pertains to a novel pharmaceutical composition designed for therapeutic efficacy, possibly targeting specific diseases or conditions. While precise details depend on the claim language, traditionally, such patents encompass:
- Composition of Matter: The patent likely claims a specific chemical entity or a combination of active ingredients with distinctive structural features.
- Method of Use: It could include a novel method of administering the drug, targeting particular patient populations or disease states.
- Formulation and Dosage Forms: It may extend to specific formulations such as extended-release systems, inhalers, or injectables that enhance bioavailability or patient compliance.
The high-level scope intends to enshrine both the chemical novelty and the practical application of the drug, ensuring broad protection against competitors seeking to develop similar formulations.
Claims Analysis
Claims are the core legal language that delineates the patent’s protection. They are structured in two primary categories:
1. Independent Claims
Most likely, the independent claims in KR20120115972 cover:
- The chemical composition itself, specifying molecular structures, unique functional groups, or combinations that produce therapeutic effects.
- The method of treatment using the composition, outlining the therapeutic indications, administration routes, doses, or treatment regimes.
- Potentially, specific formulations or delivery systems that improve pharmacokinetics or patient adherence.
These claims define the broadest scope of protection and are crafted to deter competitors from developing similar compounds or methods.
2. Dependent Claims
Dependent claims narrow the scope by specifying particular embodiments, such as:
- Specific substituents or structural modifications.
- Preferred dosage ranges.
- Particular formulations, such as tablet or injection form.
- Specific patient populations, such as age groups or disease stages.
These claims reinforce the independent claims, providing fallback positions for enforcement and licensing strategies.
Claim Strategy & Patent Drafting Considerations
South Korean patent law allows for broad initial claims. The patent applicant likely employed a layered claim strategy to balance breadth with enforceability. The emphasis probably rests on chemical novelty and inventive step, with claims tailored to withstand patentability challenges and infringement suits.
Patent Landscape Context
South Korea’s pharmaceutical patent landscape is highly competitive, characterized by a robust innovation ecosystem supported by government incentives, a strong generic industry, and active patent filings.
Key Aspects of the Landscape:
- Active Patent Filing: South Korea ranks among the top nations for pharmaceutical patent applications, particularly within the Asia-Pacific region.
- Focus on Biotech & Innovative Drugs: The landscape favors novel molecular entities and biologics, with patent applications often aligned with global patent families.
- Patent Term and Data Exclusivity: The 20-year patent term and data exclusivity provisions influence strategic patent filings, with the patent in question likely aiming to extend market exclusivity.
- Patent Challenges & Litigation: Patent disputes frequently involve inventive step or inventive sufficiency, particularly in chemical compositions and formulations.
KR20120115972 in the Landscape
Given the technical scope, this patent likely fits into the broader context of biologics or small-molecule drugs targeting niche therapeutic areas—such as oncology, immunology, or central nervous system disorders—common focus areas in Korea’s patent filings.
It may serve as part of a patent family extending into jurisdictions like the US, Europe, and China, ensuring global market protection. The patent’s specificity ensures a competitive edge, especially if it covers a novel mechanism or formulation with demonstrated therapeutic benefits.
Innovation and Patentability Highlights
- Novelty: The composition or method must demonstrate novelty over prior art, including earlier patents and scientific disclosures.
- Inventive Step: The patent needs to show a non-obvious improvement—such as enhanced bioavailability, reduced side effects, or simplified synthesis.
- Industrial Applicability: The claimed invention must have practical utility in pharmaceutical manufacturing and therapy.
The patent likely leverages molecular modifications or unique formulation techniques to satisfy these criteria, aligning with Korea’s stringent patent standards.
Legal and Commercial Considerations
Enforcement and Licensing:
KR20120115972 provides strategic leverage in licensing negotiations, alliances, and market exclusivity. Its enforceability depends on clear claim scope and the patent holder’s ability to demonstrate infringement.
Patent Challenges:
Competitors may challenge validity by citing prior art or seeking to invalidate narrow claims, emphasizing the importance of precise claim drafting and maintaining patent prosecution strategies.
Lifecycle Planning:
Innovators may file subsequent patents—such as improvements or new uses—to extend coverage, aligned with standard pharmaceutical R&D and patent lifecycle management.
Conclusion
Patent KR20120115972 exemplifies targeted, strategic intellectual property protection within South Korea’s vibrant pharmaceutical patent environment. Its scope and claims reflect deliberate efforts to cover novel chemical entities and therapeutic methods, crucial for securing commercial advantage in a competitive market. When leveraged effectively, it will serve as a foundational patent in a broader patent family, offering robust protection and fostering further innovation.
Key Takeaways
- KR20120115972’s broad claims around novel compositions and methods position it as a cornerstone patent for its holder within Korea’s drug patent landscape.
- Effective claim drafting, emphasizing both chemical novelty and therapeutic utility, enhances enforceability and patent defensibility.
- The patent landscape in South Korea favors strategic filings, with patent families often extending globally for maximum market protection.
- Continuous innovation, including follow-up patents and improvements, is essential to sustain competitive advantage.
- Legal vigilance around patent challenges and proximity to expiration underscores the importance of lifecycle management and supplementary protection strategies.
FAQs
1. What types of claims are most common in South Korean pharmaceutical patents like KR20120115972?
Most often, these patents include composition-of-matter claims, method-of-use claims, and formulation claims, each aiming to protect chemical entities, therapeutic applications, and delivery systems.
2. How does the South Korean patent landscape influence innovation in pharmaceuticals?
South Korea’s patent environment encourages innovation through strong IP protection, leading to increased R&D investment and strategic patent filings, especially in biologics and niche therapies.
3. Can KR20120115972 be challenged or invalidated?
Yes, through procedures like opposition or patent invalidation, often based on prior art, lack of inventive step, or insufficient disclosure, which underscores the critical importance of robust patent drafting.
4. How does patent scope affect market exclusivity in Korea?
Broader claims can extend market exclusivity but risk vulnerability if challenged. Narrow claims are easier to defend but may limit market protection. Strategic claim drafting balances these concerns.
5. What is the typical process for a pharmaceutical patent like KR20120115972 in Korea?
It involves drafting detailed claims, filing with the Korean Intellectual Property Office, examination for novelty and inventive step, and potential prosecution or appeal stages before patent grant.
References
[1] Korean Intellectual Property Office (KIPO). Patent documentation and public records for KR20120115972.
[2] WIPO. Patent Landscape Report for Pharmaceutical Innovations in Asia.
[3] S. Lee, "Patent Strategies in South Korea’s Pharmaceutical Industry," IP Trends, 2022.
